(Q43607545)

20574442

25 November 2017

title

Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major (English)

1 reference

25 November 2017

Leishmania major

1 reference

7

Esther von Stebut

0 references

author name string

Katharina Kronenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Sven Brosch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Florian Butsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Yayoi Tada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Naotaka Shibagaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Mark C Udey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

Esther von Stebut

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

language of work or name

English

0 references

publication date

24 June 2010

1 reference

20574442

Journal of Investigative Dermatology

25 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

page(s)

2602-2610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.2010.171

14 May 2020

exact match

0 references

cites work

Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

1 reference

12 December 2020

CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

1 reference

12 December 2020

MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major

1 reference

12 December 2020

Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity

1 reference

12 December 2020

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

12 December 2020

Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice

1 reference

12 December 2020

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

1 reference

12 December 2020

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

12 December 2020

Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).

1 reference

12 December 2020

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

1 reference

12 December 2020

Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major

1 reference

12 December 2020

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

12 December 2020

Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity

1 reference

12 December 2020

Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response

1 reference

12 December 2020

Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity

1 reference

12 December 2020

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

12 December 2020

Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

1 reference

12 December 2020

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

1 reference

12 December 2020

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis.

1 reference

12 December 2020

Immune responses in kala-azar.

1 reference

12 December 2020

Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis

1 reference

12 December 2020

Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.

1 reference

12 December 2020

Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma

1 reference

12 December 2020

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

1 reference

12 December 2020

Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study

1 reference

12 December 2020

Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection

1 reference

12 December 2020

A new view on cutaneous dendritic cell subsets in experimental leishmaniasis

1 reference

12 December 2020

The regulation of immunity to Leishmania major

1 reference

12 December 2020

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

1 reference

12 December 2020

The immunology of Leishmania infection and the implications for vaccine development

1 reference

12 December 2020

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

12 December 2020

Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells

1 reference

12 December 2020

Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection

1 reference

12 December 2020

Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells

1 reference

12 December 2020

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells

1 reference

12 December 2020

Expression cloning of a protective Leishmania antigen

1 reference

12 December 2020

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells

1 reference

12 December 2020

Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens

1 reference

12 December 2020

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c

1 reference

12 December 2020

Advances in leishmaniasis

1 reference

12 December 2020

T-cell response in human leishmaniasis

1 reference

12 December 2020

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

12 December 2020

Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer

1 reference

12 December 2020

Fc gamma receptors and cross-presentation in dendritic cells

1 reference

12 December 2020

Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania

1 reference

12 December 2020

Identifiers

DOI

10.1038/JID.2010.171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

Dimensions Publication ID

14 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6999697&resulttype=core&format=json

14 May 2020

20574442

1 reference